PitchSend

Investor Presentaiton

9MFY23 Non-Covid MHP (excl. PPP Contracts) Revenues up by 13% for Q3 FY23 Q3FY23 Non-Covid MHL (excl. PPP Contracts) 208 Q3FY22 +13% 235 8 METROPOLIS The Pathology Specialist PPP Contracts Covid PCR & Covid Allied Hi-Tech Diagnostics Total Revenues +200% -88% 23 61 8 17 +20% -3% 20 20 293 286 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Non-Covid MHL (excl. PPP Contracts) 607 +15% PPP Contracts Covid PCR & Covid Allied Hi-Tech Diagnostics Total Revenues +3% -84% -6% 700 63 65 235 Hitech revenues not comparable, 64 922 866 since it was acquired in Q3FY22 9MFY22 9MFY23 Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021 17 37 9MFY22 9MFY23 9MFY22 9MFY23 9MFY22 9MFY23 9MFY22 9MFY23 7

View entire presentation